hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis

doi:10.3748/wjg.v22.i6.2060

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9525)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

629

WORD

299

HTML

4912

Figures (1-6)

164

Tables (1-1)

150

Sum=6154

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1271

Download

2100

Sum=3371

Feb 14, 2016 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 14, 2016; 22(6): 2060-2070
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2060

Full Size Figure Download Figure

Figure 4 Receiver operating characteristic curve analysis of hsa-miR-29c (A-E) and hsa-miR-135b (F-J) expression. Gastric lesions: Non-atrophic chronic gastritis and intestinal metaplasia; Others: Non-atrophic chronic gastritis, intestinal metaplasia and intestinal-type gastric adenocarcinoma; AUC: Area under the curve.

Citation: Vidal AF, Cruz AM, Magalhães L, Pereira AL, Anaissi AK, Alves NC, Albuquerque PJ, Burbano RM, Demachki S, Ribeiro-dos-Santos Â. hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis. World J Gastroenterol 2016; 22(6): 2060-2070
URL: https://www.wjgnet.com/1007-9327/full/v22/i6/2060.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i6.2060